Secura Bio
Latest round
- Series A
Last raised
- Mar 2019
Total raised
- $55M
Investors
- 1
About Secura Bio
Based in Nevada, US, Secura Bio, Inc. is a biopharmaceutical company that engages in developing and commercializing medicines and oncology therapies for doctors and their patients. The company offers FARYDAK, a treatment for patients with cancer called multiple myeloma.
Who invested in Secura Bio
1 investor across 1 round
See all investors in Secura Bio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Mar 5, 2019
Amount
$55M
Investors
Questions about Secura Bio
Who invested in Secura Bio?
Secura Bio has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Secura Bio raised?
Secura Bio has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Secura Bio last raise money?
Secura Bio's most recent round on record is a Series A, in Mar 2019.
What does Secura Bio do?
Based in Nevada, US, Secura Bio, Inc.
Where is Secura Bio headquartered?
Secura Bio is headquartered in Las Vegas, US.
Which VCs invest in companies like Secura Bio?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Secura Bio's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Secura Bio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.